ZA200907240B - Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods - Google Patents
Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methodsInfo
- Publication number
- ZA200907240B ZA200907240B ZA200907240A ZA200907240A ZA200907240B ZA 200907240 B ZA200907240 B ZA 200907240B ZA 200907240 A ZA200907240 A ZA 200907240A ZA 200907240 A ZA200907240 A ZA 200907240A ZA 200907240 B ZA200907240 B ZA 200907240B
- Authority
- ZA
- South Africa
- Prior art keywords
- compositions
- treatment
- melanomas
- procedures
- prepare
- Prior art date
Links
- 238000000034 method Methods 0.000 title 2
- 239000000203 mixture Substances 0.000 title 2
- 201000001441 melanoma Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
- A61K39/00119—Melanoma antigens
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/461—Cellular immunotherapy characterised by the cell type used
- A61K39/4615—Dendritic cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
- A61K39/4622—Antigen presenting cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/46449—Melanoma antigens
- A61K39/464491—Melan-A/MART
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/46—Cellular immunotherapy
- A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
- A61K39/4643—Vertebrate antigens
- A61K39/4644—Cancer antigens
- A61K39/46449—Melanoma antigens
- A61K39/464492—Glycoprotein 100 [Gp100]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5152—Tumor cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/876—Skin, melanoma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
- A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cell Biology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP070101520A AR060424A1 (es) | 2007-04-11 | 2007-04-11 | Lineas celulares , composiciones para el tratamiento de melanomas que las comprenden procedimientos para preparar las composiciones y metodos de tratamiento |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA200907240B true ZA200907240B (en) | 2010-07-28 |
Family
ID=39590605
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA200907240A ZA200907240B (en) | 2007-04-11 | 2009-10-16 | Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods |
Country Status (17)
Country | Link |
---|---|
US (1) | US8501168B2 (xx) |
EP (1) | EP2146742B1 (xx) |
JP (1) | JP5762738B2 (xx) |
KR (1) | KR101502518B1 (xx) |
CN (1) | CN101861163B (xx) |
AR (1) | AR060424A1 (xx) |
AU (1) | AU2008238909B2 (xx) |
BR (1) | BRPI0809767B1 (xx) |
CA (1) | CA2683629C (xx) |
CO (1) | CO6260100A2 (xx) |
DK (1) | DK2146742T3 (xx) |
ES (1) | ES2390130T3 (xx) |
MX (1) | MX2009010927A (xx) |
NZ (1) | NZ580533A (xx) |
RU (1) | RU2484134C2 (xx) |
WO (1) | WO2008126039A2 (xx) |
ZA (1) | ZA200907240B (xx) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6077735B2 (ja) * | 2011-06-08 | 2017-02-08 | 日本電子株式会社 | 電子顕微鏡観察用染色剤および電子顕微鏡観察用試料の染色方法 |
SG11201401632WA (en) | 2011-10-20 | 2014-05-29 | California Stem Cell Inc | Antigen presenting cancer vaccine |
JP6077757B2 (ja) * | 2012-04-17 | 2017-02-08 | 日本電子株式会社 | 電子顕微鏡観察用染色剤および電子顕微鏡観察用試料の染色方法 |
JP5921386B2 (ja) * | 2012-08-27 | 2016-05-24 | 日本電子株式会社 | 電子顕微鏡観察用染色剤および電子顕微鏡観察用試料の染色方法 |
CN103146641B (zh) * | 2013-02-06 | 2015-03-25 | 云南中科灵长类生物医学重点实验室 | 多能干细胞的传代方法及其用途 |
CN104990781B (zh) * | 2015-06-29 | 2018-02-16 | 中国医学科学院皮肤病研究所 | 黑素细胞免疫组化苏木素—甲苯胺蓝双重复染法 |
TW202134430A (zh) | 2019-12-03 | 2021-09-16 | 美商紐沃進公司 | 腫瘤細胞疫苗 |
RU2755233C1 (ru) * | 2021-01-11 | 2021-09-14 | Сергей Анатольевич Яргунин | Способ лечения меланомы кожи IIb-IIc стадий |
CN115074328A (zh) * | 2022-06-21 | 2022-09-20 | 中国人民解放军空军军医大学 | 一种用于治疗黑素瘤的细胞株及其多效价全细胞疫苗与使用方法 |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5882654A (en) * | 1989-11-03 | 1999-03-16 | Morton; Donald L. | Polyvalent melanoma vaccine |
AU705647B2 (en) * | 1996-07-10 | 1999-05-27 | Immunex Corporation | Method of activating dendritic cells |
ATE283069T1 (de) * | 1996-08-16 | 2004-12-15 | Univ Johns Hopkins Med | Melanomzellinien, welche immundominante melanomantigene teilen und verfahren zu deren anwendung |
CA2321093A1 (en) * | 1998-02-20 | 1999-08-26 | The Rockefeller University | Apoptotic cell-mediated antigen presentation to dendritic cells |
EP2151245A1 (en) * | 1999-10-15 | 2010-02-10 | Baylor Research Institute | Use of allogeneic cell lines to load antigen-presenting cells to elicit or eliminate immune responses |
WO2001028583A2 (en) * | 1999-10-18 | 2001-04-26 | St. Vincent's Hospital And Medical Center Of New York | Melanoma vaccine and methods of making and using same |
US7015205B1 (en) * | 1999-10-18 | 2006-03-21 | St. Vincent's Hospital And Medical Center Of New York | Melanoma vaccine and methods of making and using same |
WO2001048154A1 (fr) * | 1999-12-28 | 2001-07-05 | Toyoshima, Kumao | Agent de maturation pour cellules dendritiques immatures |
ATE371017T1 (de) * | 2000-09-15 | 2007-09-15 | Ortho Mcneil Pharm Inc | Zusammensetzungen und verfahren zur auslösung spezifischer zytolytischer t-zellantworten |
US20030072737A1 (en) * | 2000-12-29 | 2003-04-17 | Michael Brines | Tissue protective cytokines for the protection, restoration, and enhancement of responsive cells, tissues and organs |
IL140796A0 (en) * | 2001-01-08 | 2002-02-10 | Hadasit Med Res Service | An autologous anti-cancer vaccine |
JP2004536787A (ja) * | 2001-03-09 | 2004-12-09 | ベイラー リサーチ インスティテュート | 血液免疫反応の誘導による悪性腫瘍治療方法 |
WO2003020884A2 (en) * | 2001-08-14 | 2003-03-13 | The Government Of The United States Of America As Represented By The Secretary Of Health And Human Services | Method for rapid generation of mature dendritic cells |
EP1451305A4 (en) * | 2001-11-07 | 2005-10-05 | Mannkind Corp | EPITOPE SYNCHRONIZATION IN CELLS THAT HAVE ANTIGENS |
ES2354944T3 (es) * | 2002-12-06 | 2011-03-21 | Northwest Biotherapeutics, Inc. | Administración de células dendríticas maduradas parcialmente in vitro para el tratamiento de tumores. |
AU2004239288B2 (en) * | 2003-05-09 | 2010-01-28 | Centocor, Inc. | IL-23p40 specific immunoglobulin derived proteins, compositions, methods and uses |
JP5021309B2 (ja) * | 2003-10-16 | 2012-09-05 | ステファン ジョン ラルフ | 免疫調節性組成物およびその使用方法 |
RU2262941C2 (ru) | 2004-01-05 | 2005-10-27 | Государственное учреждение Научно-исследовательский институт клинической иммунологии СО РАМН | Способ иммунотерапии злокачественных опухолей головного мозга |
JP5848861B2 (ja) * | 2004-04-20 | 2016-01-27 | ジェンマブ エー/エスGenmab A/S | Cd20に対するヒトモノクローナル抗体 |
CA2565874C (en) * | 2004-05-10 | 2017-10-03 | Macrogenics, Inc. | Humanized fc.gamma.riib-specific antibodies and methods of use thereof |
RU2283129C1 (ru) | 2004-12-24 | 2006-09-10 | Сергей Викторович Луценко | Белковопептидный противоопухолевый композит, клеточный препарат, активированный этим композитом, и способ профилактики или лечения опухолей |
-
2007
- 2007-04-11 AR ARP070101520A patent/AR060424A1/es active IP Right Grant
-
2008
- 2008-04-11 BR BRPI0809767-4A patent/BRPI0809767B1/pt active IP Right Grant
- 2008-04-11 WO PCT/IB2008/051385 patent/WO2008126039A2/en active Application Filing
- 2008-04-11 MX MX2009010927A patent/MX2009010927A/es active IP Right Grant
- 2008-04-11 ES ES08737810T patent/ES2390130T3/es active Active
- 2008-04-11 DK DK08737810.5T patent/DK2146742T3/da active
- 2008-04-11 CA CA2683629A patent/CA2683629C/en active Active
- 2008-04-11 AU AU2008238909A patent/AU2008238909B2/en active Active
- 2008-04-11 NZ NZ580533A patent/NZ580533A/xx unknown
- 2008-04-11 RU RU2009141593/10A patent/RU2484134C2/ru active
- 2008-04-11 JP JP2010502629A patent/JP5762738B2/ja active Active
- 2008-04-11 EP EP08737810A patent/EP2146742B1/en active Active
- 2008-04-11 US US12/450,721 patent/US8501168B2/en active Active
- 2008-04-11 CN CN2008800182498A patent/CN101861163B/zh active Active
- 2008-04-11 KR KR1020097022846A patent/KR101502518B1/ko active IP Right Grant
-
2009
- 2009-10-16 ZA ZA200907240A patent/ZA200907240B/xx unknown
- 2009-10-28 CO CO09121156A patent/CO6260100A2/es active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
CN101861163A (zh) | 2010-10-13 |
US8501168B2 (en) | 2013-08-06 |
MX2009010927A (es) | 2010-02-11 |
AR060424A1 (es) | 2008-06-18 |
AU2008238909B2 (en) | 2013-11-07 |
BRPI0809767A2 (pt) | 2014-09-23 |
US20100183683A1 (en) | 2010-07-22 |
JP2010523141A (ja) | 2010-07-15 |
RU2484134C2 (ru) | 2013-06-10 |
KR20090129501A (ko) | 2009-12-16 |
ES2390130T3 (es) | 2012-11-06 |
BRPI0809767B1 (pt) | 2022-04-12 |
CO6260100A2 (es) | 2011-03-22 |
WO2008126039A2 (en) | 2008-10-23 |
NZ580533A (en) | 2012-08-31 |
DK2146742T3 (da) | 2012-10-22 |
CN101861163B (zh) | 2013-06-12 |
KR101502518B1 (ko) | 2015-03-13 |
AU2008238909A1 (en) | 2008-10-23 |
EP2146742B1 (en) | 2012-07-11 |
CA2683629C (en) | 2016-06-21 |
WO2008126039A3 (en) | 2008-12-11 |
RU2009141593A (ru) | 2011-05-20 |
EP2146742A2 (en) | 2010-01-27 |
CA2683629A1 (en) | 2008-10-23 |
JP5762738B2 (ja) | 2015-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL202015A0 (en) | Methods and compositions for treating skin conditions | |
ZA200907240B (en) | Cell lines, compositions comprising them for the treatment of melanomas, procedures to prepare the compositions, and treatment methods | |
EP2361089A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED FUNCTION OF -SYNUCLEINE | |
IL220129A (en) | History of benzamide, preparations containing them and their use in the treatment of cancer | |
IL208458A0 (en) | Compositions and methods for skin care | |
IL202329A0 (en) | Methods and compositions for stimulating cells | |
HK1148906A1 (en) | Compositions and methods for cancer treatment | |
EP2391208A4 (en) | COMPOSITIONS FOR THE TREATMENT OF NAILS AND SKIN | |
EP2212440A4 (en) | METHOD AND COMPOSITIONS FOR DIAGNOSIS AND TREATMENT OF ADENOCARCINOMES OF DISHES | |
HK1159498A1 (en) | Methods and compositions for the treatment of cancer | |
IL210810A0 (en) | Compositions for the treatment of pain and/or inflamtion | |
EP2124985A4 (en) | METHOD AND COMPOSITIONS FOR TREATING NERVOUS ELEMENTS | |
HK1166305A1 (zh) | 用於治療炎症的組合物及方法 | |
HK1245679A1 (zh) | 用於治療皮膚疾病和病症的方法和組合物 | |
GB0718446D0 (en) | Compositions and methods for the treatment of infection | |
EP2429584A4 (en) | TREATMENT PROCEDURE AND COMPOSITIONS | |
EP2340027A4 (en) | METHODS AND COMPOSITIONS FOR THE TREATMENT OF CANCER | |
EP2249789A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF XEROSOMY | |
IL214349A0 (en) | Compositions and methods for the treatment of cancer | |
PL2209458T3 (pl) | Kompozycje do traktowania skóry | |
PT2403336E (pt) | Composições de tratamento de plantas e métodos para a sua utilização | |
GB0909297D0 (en) | Composition for the treatment of skin conditions | |
EP2437738A4 (en) | METHOD AND COMPOSITIONS FOR CANCER TREATMENT | |
EP2150270A4 (en) | METHODS AND COMPOSITIONS FOR TREATING CANCER | |
GB0718918D0 (en) | Compositions and methods for treating skin conditions |